OBGYN.net: The Universe of Women's Health

Date and Place of Birth:

August 20, 1942, Goor, The Netherlands

Marital Status:

Married (1968), two children

University Education:

• M.D. 1967: Free University, Amsterdam, The Netherlands
• Ph.D. 1980: Catholic University, Nijmegen, The Netherlands

Present Position:

• 1987 - Professor Obstetrics and Gynaecology,
• 1989 - Chairman Department Obstetrics and Gynaecology
  Director Menopause project "Ageing Women"
  University Hospital Vrije Universiteit, De Boelelaan 1117,
  1081 HV Amsterdam, The Netherlands
  tel: 31 20 444 4813, fax: 31 20 444 4811

Major Clinical Interest:

• Gynaecological Oncology
• Patient tailored management of the menopause

Major Research Interest:

• Monoclonal Antibodies in diagnosis and therapy
• Immunotherapy of cancer
• Familial Cancer Syndroms
• HRT and Cancer

Professional Societies:

• Dutch Society of Obstetrics and Gynaecology, member (1974 - )
• Eur. Society for Gynaecological Oncology, member (1984 - )
• Eur. Society for Medical Oncology, member (1985 - )
• Dutch Society of Gynecologic Oncology, board member (1995 - 1998)
• North American Menopause Society (1996 - )
• Eur. Menopause Society (1997 - )

Editorships/Advisory Boards:

• European Journal of Obstetrics & Gynecology and Reproductive Biology (1993 - )
• Cancer Molecular Biology ( 1994 - )
• Tijdschrift voor Climacterium & Postmenopauze, Editor-in-Chief, (1994 - 1996)
• European Menopause Journal, Editor-in-Chief, (1994 - 1998)
• Practical Cases on Menopause (1996 - )
• American Journal of Obstetrics and Gynecology, corresponding editor (1997 - )
• Climacteric (1998 - )
• Women and Cancer (1998 - )
• Maturitas, the EMJ, Editor-in-Chief (1998 - )

Recent HRT Publications (Books, Proceedings):

• Practical HRT (second edition).
• Medical Forum International, Zeist, The Netherlands, ISBN 90-5698-008-4, 215 pp. (1996).
• Kenemans P, R Barentsen, PHM van de Weijer (Authors).
• Age, menopause, cardiovascular disease and HRT.
• Proceedings of the Novo Nordisk Expert Workshop, Heemskerk, The Netherlands. ISBN 90-75141-26-2 (1996).
• Weijer PHM van de, P Kenemans, R Barentsen (Eds).
• Women's Health and Menopause. Risk Reduction Strategies.
• Kluwer Academic Publishers, Dordrecht, The Netherlands. ISBN 0-7923-4697-1, 340 p. (1997).
• Paoletti R, PG Crosignani, P Kenemans, G Samsioe, M Soma (Eds).

Recent HRT Publications (Papers 1997 onwards):

Crosignani PG, P Kenemans, R Paoletti, MR Soma, FP Woodford.
Hormone replacement and the menopause: a European position paper.
Eur J Obstet Gynecol Reprod Biol 1997;74:67-72.

Kenemans P.
Risks and benefits of long-term HRT: a calculated risk?
Eur J Obstet Gynecol Reprod Biol 1997;71:187.

Kenemans P, F Scheele.
Hormone replacement therapy in patients at high risk of developing breast cancer: the use of a combined risk model.
Gynecol Endocrinol 1997;11(S1):17-22.

Kenemans P, F Scheele, CW Burger.
Hormone replacement therapy and breast cancer morbidity, mortality and recurrence.
Eur J Obstet Gynecol Reprod Biol 1997;71:199-203.

Mijatovic V, P Kenemans, JC Netelenbos, ERA Peters-Muller, GJ van Kamp, GA Voetberg, PHM van de Weijer, MJ van der Mooren.
Oral 17-b oestradiol continuously combined with dydrogesterone lowers serum lipoprotein(a) concentrations in healthy postmenopausal women.
J Clin Endocrinol Metab 1997;82:3543-3547.

Pines A, V Mijatovic, MJ van der Mooren, P Kenemans. Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations.
Eur J Obstet Gynecol Reprod Biol 1997;71:193-197.

Scheele F, P Kenemans.
HRT in patients at high risk of primary or recurrent breast cancer.
Menopause Review 1997;2:48-55.

Valk-de Roo GW de, JC Netelenbos, IRA Peters-Muller, GA Voetberg, PHM van de Weijer, AA Bouman, C Popp-Snijders, P Kenemans.
Continuously combined hormone replacement therapy and bone turnover: the influence of dydrogesterone dose, smoking and initial degree of bone turnover.
Maturitas 1997;28:153-162.

Burger CW, P Kenemans.
Postmenopausal hormone replacement therapy and cancer of the female genital tract and breast.
Current Opinion Obstet Gynecol 1998;10:41-45.

Ittersum FJ van, WM van Baal, P Kenemans, V Mijatovic, AJM Donker, MJ van der Mooren, CDA Stehouwer.
Ambulatory -not office- blood pressures decline during hormone replacement therapy in postmenopausal women.
Am J Hypertension 1998;11:1147-1152.

Kenemans P.
Estrogens and antiestrogens: Basic and clinical aspects (ed. Lindsay, Dempster, Jordan).
Bookreview.
N Engl J Med 1998;338:1079.

Mijatovic V, P Kenemans, C Jakobs, WM van Baal, ERA Peters-Muller, MJ van der Mooren.
A randomized controlled study of the effects of 17b-estradiol-dydrogesterone on plasma homocysteine in postmenopausal women.
Obstet Gynecol 1998;91:432-436.

Mijatovic V, P Kenemans, CJ Netelenbos, C Jakobs, C Popp-Snijders, ERA Peters-Muller, MJ van der Mooren.
Postmenopausal oral 17B-oestradiol continuously combined with dydrogesterone reduces fasting serum homocysteine levels.
Fertil Steril 1998;69:876-882.

Weijer PHM van de, R Barentsen, P Kenemans.
Women's expectations and acceptance of cyclic induced HRT bleeds.
Maturitas EMJ 1998;30:257-263.

Baal WM van, P Kenemans, JJ Emeis, CG Schalkwijk, V Mijatovic, MJ van der Mooren, UM Vischer, CDA Stehouwer.
Long-term effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity in healthy postmenopausal women.
Fertil Steril 1999;71:663-670.

Burger CW, FE van Leeuwen, F Scheele, P Kenemans.
Hormone replacement therapy in women treated for gynaecological malignancy.
Maturitas EMJ 1999 (in press)